| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 07/05/2000 | EP1016418A2 Composition comprising a recombinant virus expressing an antigen and a recombinant virus expressing an immunostimulatory molecule |
| 07/05/2000 | EP1016416A2 Vaccine against lyme disease and a challenge model for evaluating vaccine efficacy |
| 07/05/2000 | EP1016406A1 Ophthalmic compositions for soft contact lens, method of enhancing wettability of soft contact lens, and method of inhibiting terpenoid adsorption |
| 07/05/2000 | EP1015630A1 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes |
| 07/05/2000 | EP1015604A1 Human prl-1 phosphatase |
| 07/05/2000 | EP1015602A1 Glutrna gln amidotransferase - a novel essential translational component |
| 07/05/2000 | EP1015596A1 Fusion proteins comprising hiv-1 tat and/or nef proteins |
| 07/05/2000 | EP1015595A1 Peptides derived from the attachment (g) protein of respiratory syncytial virus |
| 07/05/2000 | EP1015593A1 Hepatitis b virus polypeptides |
| 07/05/2000 | EP1015572A2 Nuclear transfer with differentiated fetal and adult donor cells |
| 07/05/2000 | EP1015493A1 Novel epithelial tissue targeting agent |
| 07/05/2000 | EP1015485A1 Macrophage derived chemokine (mdc) as an anti-viral agent for the treatment and prevention of lentivirus infections |
| 07/05/2000 | EP1015481A1 Antigenic structural peptide, antigenic and immunogenic compounds and uses for detecting, preventing and treating an hcv infection |
| 07/05/2000 | EP1015472A1 Uses of nicotinamide adenine dinucleotide and its analogs for treatment of malignant and infectious diseases |
| 07/05/2000 | EP1015469A2 Bi- and tri-cyclic nucleoside, nucleotide and oligonucleoide analogues |
| 07/05/2000 | EP1015467A1 6,9-bridged erythromycin derivatives |
| 07/05/2000 | EP1015464A2 SYNTHETIC DIVALENT sLex CONTAINING POLYLACTOSAMINES AND METHODS FOR USE |
| 07/05/2000 | EP1015459A1 Tetrazole-containing rapamycin analogs with shortened half-lives |
| 07/05/2000 | EP1015458A1 Furopyrrolidine derivatives and their use as serine protease inhibitors |
| 07/05/2000 | EP1015454A1 Method of inhibiting serine protease enzymes |
| 07/05/2000 | EP1015453A1 3-(iodophenoxymethyl) carbapenem antibacterials |
| 07/05/2000 | EP1015452A1 Optionally protected 3-hydroxymethyl carbapenems and synthesis |
| 07/05/2000 | EP1015445A1 Antimicrobial quinolones, their compositions and uses |
| 07/05/2000 | EP1015441A1 Process to produce 4-hydroxy-2-oxo-pyrane derivatives useful as protease inhibitors |
| 07/05/2000 | EP1015422A1 Hiv matrix protein tyrosine position 29 pocket binders |
| 07/05/2000 | EP1015417A1 Compounds containing six-membered rings, processes for their preparation, and their use as medicaments |
| 07/05/2000 | EP1015033A2 Substituted perylenequinones for use in photodynamic therapy |
| 07/05/2000 | EP1015030A2 Photochemotherapeutic compositions |
| 07/05/2000 | EP1015026A2 Il-12 as an adjuvant for bordetella pertussis vaccines |
| 07/05/2000 | EP1015021A2 Agents for combating bacterial meningitis |
| 07/05/2000 | EP1015012A1 Peptide inhibitors of nuclear protein translocation having nuclear localization sequences and methods of use thereof |
| 07/05/2000 | EP1015011A1 Peptide nucleic acids having antibacterial activity |
| 07/05/2000 | EP1015009A1 Attenuated vif dna immunization cassettes for genetic vaccines |
| 07/05/2000 | EP1015006A2 Cocoa extract compounds and methods for making and using the same |
| 07/05/2000 | EP1014999A1 Cationic polymers as toxin-binding agents |
| 07/05/2000 | EP1014984A1 Inhibitors of prenyl-protein transferase |
| 07/05/2000 | EP1014976A1 Novel substituted imidazole compounds |
| 07/05/2000 | EP1014975A1 Method for treating chronic fatigue syndrome and fibromyalgia with buprenorphine |
| 07/05/2000 | EP1014969A1 Plant proanthocyanidin extract effective at inhibiting adherence of bacteria with p-type fimbriae to surfaces |
| 07/05/2000 | EP1014964A1 Melanins with improved ability to inhibit hiv replication |
| 07/05/2000 | EP1014804A1 Cocoa components, edible products having enhanced polyphenol content, methods of making same and medical uses |
| 07/05/2000 | EP0926956B1 Use of algae extract as antibacterial and/or antifungal agent and composition containing same |
| 07/05/2000 | EP0686151B1 Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors |
| 07/05/2000 | EP0680322B1 Use of clavulanate and an antibacterial compound for the treatment of infections |
| 07/05/2000 | CN1259171A Retroviral vector particles produced in a baculovirus expression system |
| 07/05/2000 | CN1259141A PRRSV antigenic sites identifying peptide sequences of PRRS virus for use in vaccines or diagnostic assays |
| 07/05/2000 | CN1259136A 4'-substituted-9-deoxo-9A-AZA-9A-homoerythromycin a derivatives |
| 07/05/2000 | CN1259135A 9-oxime erythromycin derivatives |
| 07/05/2000 | CN1259131A Compounds |
| 07/05/2000 | CN1259052A Aqueous immunologic adjuvant compositions of monophosphoryl lipid A |
| 07/05/2000 | CN1259051A Stabilized human papillomavirus formulations |
| 07/05/2000 | CN1258674A Pyrone carboxylic acid derivate or its salt and antibiotic with the same as effective component |
| 07/05/2000 | CN1258672A Amino-compound |
| 07/05/2000 | CN1054124C Aminoquinoline derivatives and its application of salt |
| 07/05/2000 | CN1054066C Oral liquor for tuberculosis |
| 07/05/2000 | CN1054051C Medicine for treating phthisis and its preparation |
| 07/04/2000 | US6084083 Amino acid sequence of polypeptide; for prognosis, diagnosis, monitoring, rational drug design, and/or therapeutic intervention of t helper cell related disorders including crohn's disease, lyme disease, insulin-dependent diabetes |
| 07/04/2000 | US6083995 Administering the patient 2,4-dichlorobenzyl alcohol and amylmetacresol to cure human immunodeficiency viral infections |
| 07/04/2000 | US6083992 Use of 2-methylamino-2-phenylcyclohexanone for the treatment of bacterial infections |
| 07/04/2000 | US6083981 Sulfonamide substituted aspartic acid interleukin-1β converting enzyme inhibitors |
| 07/04/2000 | US6083968 A fungicide; 1,1-difluoro-1-ethyl thienyl or ethyl thienyl oxides-2-(2,4-substituted phenyl)-3-(1h-1,2,4-tria zol-1-yl)-2-oxy or hydroxy compound |
| 07/04/2000 | US6083967 Antimicrobial agents; assay for determining the inhibitory activity of oxazolidinones to human monoamine oxidase |
| 07/04/2000 | US6083930 Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers |
| 07/04/2000 | US6083925 Nucleic acid respiratory syncytial virus vaccines |
| 07/04/2000 | US6083924 DnaB of staphylococcus aureus |
| 07/04/2000 | US6083903 Boronic ester and acid compounds, synthesis and uses |
| 07/04/2000 | US6083756 Identifying infant's susceptibility by detecting helicobacter pylori in sample of blood, saliva, dental plaque, feces or exhaled air collected from infant's mother, close relative, or person expected to come into close bodily contact |
| 07/04/2000 | US6083743 Dna and amino acid sequences; for diagnosis and treatment of infections including otitis media, epiglottitis, pneumonia, and tracheobronchitis; for immunogenic compositions/vaccines |
| 07/04/2000 | US6083722 Borrelia antigen |
| 07/04/2000 | US6083711 Proteases compositions capable of binding to said site, and methods of use thereof |
| 07/04/2000 | US6083683 Screening for an immunological response to a microorganism in an animal or sample; incubation of sample with microorganism, screening for immunoglobulin bound microorganism |
| 07/04/2000 | US6083512 Administered to cattle |
| 07/04/2000 | US6083511 Isolated equine herpesvirus-4 (ehv-4) or gh or gc polypeptides and antigenic fragments; vaccine for the protection of horses against ehv-4 infection |
| 07/04/2000 | US6083504 Human monoclonal antibodies directed against the transmembrane glycoprotein (GP41) of human immunodeficiency virus-1 (HIV-1) |
| 07/04/2000 | US6083478 Consists of a cytotoxic radionuclide and a homodimer comprising two heavy chains encoded by the expression vector designated cd4-igg2-pcdna1 (atcc no. 40952) |
| 06/29/2000 | WO2000037944A1 Kidney disease detection and treatment |
| 06/29/2000 | WO2000037943A1 Diagnosis of sepsis using the lps-binding moiety of alkaline phosphatase |
| 06/29/2000 | WO2000037679A2 Method for determining the susceptibility to developing sepsis and therapeutics for the treatment of sepsis |
| 06/29/2000 | WO2000037676A1 Method of sequence identification |
| 06/29/2000 | WO2000037648A1 Protective antigen of group a streptococci (spa) |
| 06/29/2000 | WO2000037646A2 Group b streptococcus proteins, and their use |
| 06/29/2000 | WO2000037639A2 Lymphocytic membrane proteins |
| 06/29/2000 | WO2000037635A2 Genetic suppressor elements against human immunodeficiency virus |
| 06/29/2000 | WO2000037610A2 Expression of immunogenic hepatitis b surface antigens in transgenic plants |
| 06/29/2000 | WO2000037609A2 Orally immunogenic bacterial enterotoxins expressed in transgenic plants |
| 06/29/2000 | WO2000037494A2 Chlamydia trachomatis antigens |
| 06/29/2000 | WO2000037490A2 Outer surface proteins, their genes, and their use |
| 06/29/2000 | WO2000037487A1 αvβ6 INTEGRIN INHIBITORS |
| 06/29/2000 | WO2000037477A1 Organo-phosphorus compounds and their utilization |
| 06/29/2000 | WO2000037472A2 Substituted pirroloindoles |
| 06/29/2000 | WO2000037467A1 1,8-benzonaphthyridine derivatives |
| 06/29/2000 | WO2000037464A2 4-(aminoalkoxy)benzofurans as n-myristoyltransferase inhibitors |
| 06/29/2000 | WO2000037434A1 Amide derivatives |
| 06/29/2000 | WO2000037421A1 Nephronin: a series of compounds for treatment of infectious diseases and cancer |
| 06/29/2000 | WO2000037358A1 NOVEL sPLA2 INHIBITORS |
| 06/29/2000 | WO2000037110A2 Ribavirin-pegylated interferon alfa induction hcv combination therapy |
| 06/29/2000 | WO2000037106A1 Oral vaccine against diarrhea |
| 06/29/2000 | WO2000037105A2 Streptococcus pneumoniae proteins and immunogenic fragments for vaccines |
| 06/29/2000 | WO2000037104A1 Improved recombinant hepatitis b surface antigen |
| 06/29/2000 | WO2000037103A2 Compounds for intracellular delivery of therapeutic moieties to nerve cells |